Patents by Inventor James B. Chung

James B. Chung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT USING AN INTERFERON GAMMA INHIBITOR
    Publication number: 20220144933
    Abstract: The invention encompasses methods of treatment of interferon gamma (IFN-?)-mediated diseases using IFN-? inhibitors, such as anti-huIFN-? antibodies, wherein levels of expression of one or more biomarkers are determined either before administration of the IFN-? inhibitor and/or after administration. Also contemplated are methods of treatment using particular, pharmacodynamically effective doses of an anti-huIFN-? antibody.
    Type: Application
    Filed: December 14, 2021
    Publication date: May 12, 2022
    Applicant: AMGEN INC.
    Inventors: Andrew A. WELCHER, Michael J. Boedigheimer, James B. Chung
  • Methods of treatment using an interferon gamma inhibitor
    Patent number: 11230597
    Abstract: The invention encompasses methods of treatment of interferon gamma (IFN-?)-mediated diseases using IFN-? inhibitors, such as anti-huIFN-? antibodies, wherein levels of expression of one or more biomarkers are determined either before administration of the IFN-? inhibitor and/or after administration. Also contemplated are methods of treatment using particular, pharmacodynamically effective doses of an anti-huIFN-? antibody.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: January 25, 2022
    Assignee: AMGEN INC.
    Inventors: Andrew A. Welcher, Michael J. Boedigheimer, James B. Chung
  • METHODS OF TREATMENT USING AN INTERFERON GAMMA INHIBITOR
    Publication number: 20180030132
    Abstract: The invention encompasses methods of treatment of interferon gamma (IFN-?)-mediated diseases using IFN-? inhibitors, such as anti-huIFN-? antibodies, wherein levels of expression of one or more biomarkers are determined either before administration of the IFN-? inhibitor and/or after administration. Also contemplated are methods of treatment using particular, pharmacodynamically effective doses of an anti-huIFN-? antibody.
    Type: Application
    Filed: August 31, 2017
    Publication date: February 1, 2018
    Applicant: AMGEN INC.
    Inventors: Andrew A. WELCHER, Michael J. BOEDIGHEIMER, James B. CHUNG
  • METHODS OF TREATMENT USING AN IFN gamma INHIBITOR
    Publication number: 20130142809
    Abstract: The invention encompasses methods of treatment of interferon gamma (IFN-?)-mediated diseases using IFN-? inhibitors, such as anti-huIFN-? antibodies, wherein levels of expression of one or more biomarkers are determined either before administration of the IFN-? inhibitor and/or after administration. Also contemplated are methods of treatment using particular, pharmacodynamically effective doses of an anti-huIFN-? antibody.
    Type: Application
    Filed: November 21, 2012
    Publication date: June 6, 2013
    Inventors: Andrew A. Welcher, Michael J. Boedigheimer, James B. Chung